- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06854978
R3THA Rehabilitation Feasibility and Usability Study (RETHA)
Study Overview
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Kiran Karunakaran, PhD
- Phone Number: 973-324-3590
- Email: kkarunakaran@kesslerfoundation.org
Study Locations
-
-
New Jersey
-
West Orange, New Jersey, United States, 07052
- Recruiting
- Kessler Foundation
-
Contact:
- Kiran Karunakaran, PhD
- Phone Number: 973-324-3590
- Email: kkarunakaran@kesslerfoundation.org
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- must be between the ages of 20 and 80
- must have enough movement in my arms and hands to actively interact with the video games as determined by study staff
- must have internet access at home.
- must be comfortable performing basic functions on a computer, such as browsing the internet.
- must be able to sit without a loss of balance while performing activities with my arms and hands as determined by study staff.
Exclusion Criteria:
Severe muscle spasms or stiffness (spasticity) in the affected upper limb that limits movement, as determined by study staff.
2) Thinking problems or have difficulty following instructions 3) Unable to interact with an entire computer screen due to spatial neglect 4) Difficulty understanding words spoken to me (Receptive aphasia) 5) Any other disabling nervous system condition (besides stroke) that has caused residual weakness, impaired range of motion, or spasticity 6) Severe arthritis that limits hand and arm movements 7) Not independent in functional activities/mobility prior to stroke
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Stroke
The study will enroll up to 10 participants with stroke who will be paired with trained therapists to receive R3THA telerehabilitation.
The participants with stroke will participate in 7 training sessions.
The training includes hand and arm exercises.
|
The study will enroll up to 10 participants with stroke who will be paired with trained therapists to receive R3THA telerehabilitation.
The participants with stroke will participate in 7 training sessions.
The training includes hand and arm exercises.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
System Usability Survey
Time Frame: 5 weeks
|
System Usability Scale is a well-established standardized metric used to measure usability perception of computer interfaces and products.
|
5 weeks
|
|
Exergame Questionnaire
Time Frame: 5 weeks
|
It is a questionnaire developed to assess qualitative performance of the device
|
5 weeks
|
|
Performance Survey
Time Frame: 5 weeks
|
It is a qualitative questionnaire with interview aimed at gauging the feasibility of integrating R3THA into the daily routines of individual with stroke/end users.
|
5 weeks
|
|
Fugl-Meyer Assessment for Upper Extremity
Time Frame: 5 weeks
|
A standard clinical measure to assess the level of motor impairment in individuals with stroke.
|
5 weeks
|
|
Box and Blocks Test
Time Frame: 5 weeks
|
box and blocks test is standard measure for hand dexterity and hand-eye coordination
|
5 weeks
|
|
Action Research Arm Test
Time Frame: 5 weeks
|
The standard assessment for functional performance in individuals with stroke
|
5 weeks
|
|
Kinematic Assessment
Time Frame: 5 weeks
|
Kinematic assesment to measure range of motion of the hand and arm
|
5 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Montreal Cognitive Assessment Test (MOCA)
Time Frame: 1 week
|
30-item question to assess cognitive impairment in people with stroke.
The score ranges from 0 to maximum score of 30.
Score of 30 denotes high cognitive function while 0 is low cognitive function
|
1 week
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Kiran Karunakaran, PhD, Kessler Foundation
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- R-1258-24
- 2226174 (Other Grant/Funding Number: NSF)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly